
Julian Panés
Cap de la UnitatPublicacions destacades
-
Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's disease
Autors: Ordás I, Rimola J, Alfaro I, Rodríguez S, Castro-Poceiro J, Ramírez-Morros A, Gallego M, Giner À, Barastegui R, Fernández-Clotet A, Masamunt M, Ricart E, Panés J .Referència: Gastroenterology 2019. -
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Autors: Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Diez MC, Tagarro I, Leselbaum A, Danese S, ADMIRE CD Study Group Collaborators.Referència: Gastroenterology 2018. -
Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis
Autors: Dotti I., Mora-Buch R., Ferrer-Picón E., Planell N., Jung P., Masamunt M., Leal R., De Carpi J., Llach J., Ordás I., Batlle E., Panés J., Salas A..Referència: Gut 2017. -
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.
Autors: Panés J, Sandborn WJ, Schreiber S, Sands BE, Vermeire S, D'Haens G, Panaccione R, Higgins PDR, Colombel JF, Feagan BG, Chan G, Moscariello M, Wang W, Niezychowski W, Marren A, Healey P, Maller E .Referència: Gut 2017. -
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Autors: Sandborn, William J.; Su, Chinyu; Sands, Bruce E.; D'Haens, Geert R.; Vermeire, Severine; Schreiber, Stefan; Danese, Silvio; Feagan, Brian G.; Reinisch, Walter; Niezychowski, Wojciech; Friedman, Gary; Lawendy, Nervin; Yu, Dahong; Woodworth, Deborah; Mukherjee, Arnab; Zhang, Haiying; Healey, Paul; Panes, Julian;OCTAVE Induction 1 OCTAVE Inductio.Referència: New England Journal Of Medicine 2017. -
Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease
Autors: Jauregui-Amezaga A, Rovira M, Marín P, Salas A, Pinó-Donnay S, Feu F, Elizalde JI, Fernández-Avilés F, Martínez C, Gutiérrez G, Rosiñol L, Carreras E, Urbano A, Lozano M, Cid J, Suárez-Lledó M, Mensa J, Rimola J, Rodríguez S, Masamunt MC, Comas D, Ruíz I, Ramírez-Morros A, Gallego M, Ordás I, Panés J, Ricart E .Referència: Gut 2016. -
Commensal-Specific CD4(+) Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile
Autors: Calderon-Gomez, Elisabeth; Bassolas-Molina, Helena; Mora-Buch, Rut; Dotti, Isabella; Planell, Nuria; Esteller, Miriam; Gallego, Marta; Marti, Merce; Garcia-Martin, Carme; Martinez-Torro, Carlos; Ordas, Ingrid; Singh, Sharat; Panes, Julian; Benitez-Ribas, Daniel; Salas, Azucena;.Referència: Gastroenterology 2016. -
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: A phase 3 randomised, double-blind controlled trial
Autors: Panes J; Garcia-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S.Referència: Lancet 2016. -
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease
Autors: Rimola, J; Rodriguez, S; Garcia-Bosch, O; Ordas, I; Ayala, E; Aceituno, M; Pellise, M; Ayuso, C; Ricart, E; Donoso, L; Panes, J.Referència: Gut 2009.
Projectes destacats
-
Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)
Investigador/a principal: Maria Azucena Salas Martinez, Julian Panes DiazFinançador: Ministerio de Ciencia, Innovación y Universidades (Programa financiador competitivo)Codi: RTI2018-096946-B-I00Durada: 01/01/2019 - 31/12/2021 -
Efficacy and safety of autologous hematopoietic stem cells transplantation for refractory Crohn's disease
Investigador/a principal: Elena RicartFinançador: Instituto de Salud Carlos III (Programa financiador competitivo)Codi: PI17/00513Durada: 01/01/2018 - 31/12/2020 -
IBD over time: Cellular Mechanisms in Crohn’s Disease Revealing new therapeutic avenues
Investigador/a principal: Maria Azucena Salas MartinezFinançador: The Leona M and Harry B Helmsley Charitable TrustCodi: HemsleyDurada: 02/01/2014 - 31/12/2017 -
New siRNA nanotherapy for inflammatory bowel diseases, targeting Janus kinase 3
Investigador/a principal: Fabrice Navarro, Maria Azucena Salas Martinez, Julian Panes DiazCodi: NEW DEAL H2020Durada: 01/01/2017 - 31/12/2020 -
Autologous Hematopoietic Stem Cell Transplant in Crohn's Disease: genetic, Immune and Microbiome factors involved in disease control (TrIM)
Investigador/a principal: Julian Panes DiazCodi: SAF 2012-33560Durada: 02/01/2013 - 31/12/2015